Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
602
Millions of yenWording
Definitive
How definitive the wording is.Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 15 May 2026Net SalesConsolidated38,900→39,561Millions of yen
+1.7%
Net SalesIndividual25,200→25,844Millions of yen
+2.6%
Operating profitConsolidated110→712Millions of yen
+547.3%
Operating profitIndividual-660→218Millions of yen
+133.0%
Ordinary incomeConsolidated330→827Millions of yen
+150.6%
Ordinary incomeIndividual-60→717Millions of yen
+1,295.0%
Profit attributable to owners of the parentConsolidated-94→386Millions of yen
+510.6%
Profit attributable to owners of the parentIndividual-290→528Millions of yen
+282.1%
Net income per shareConsolidated-3→12.34/ sen
+511.3%
Net income per shareIndividual-9.24→16.84/ sen
+282.3%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
Operating profit, ordinary profit and interim net income exceeded plan, primarily because unit prices remained firm, although sales volume in the core domestic mushroom business was slightly below plan.
Previous-period resultsConsolidated: Revenue of ¥38,080 million, operating profit of ¥58 million, ordinary profit of ¥307 million, interim net income attributable to owners of the parent of ¥1,401 million, and interim net income per share of ¥44.79. Non-consolidated: Revenue of ¥24,587 million, operating loss of ¥634 million, ordinary loss of ¥146 million, interim net income of ¥1,124 million, and interim net income per share of ¥35.94.
Consolidated / non-consolidatedConsolidated and non-consolidated
| Item | Details |
|---|---|
| Net Sales | Consolidated 38,900 / Individual 25,200 → Consolidated 39,561 / Individual 25,844（Consolidated 1.7% / Individual 2.6%） |
| Operating profit | Consolidated 110 / Individual -660 → Consolidated 712 / Individual 218（Consolidated 547.7% / Individual Not disclosed） |
| Ordinary income | Consolidated 330 / Individual -60 → Consolidated 827 / Individual 717（Consolidated 150.6% / Individual Not disclosed） |
| Profit attributable to owners of the parent | Consolidated -94 / Individual -290 → Consolidated 386 / Individual 528 |
| Net income per share | Consolidated -3 / Individual -9.24 → Consolidated 12.34 / Individual 16.84 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 15 May 2026 |
| Previous-period results | Consolidated: Revenue of ¥38,080 million, operating profit of ¥58 million, ordinary profit of ¥307 million, interim net income attributable to owners of the parent of ¥1,401 million, and interim net income per share of ¥44.79. Non-consolidated: Revenue of ¥24,587 million, operating loss of ¥634 million, ordinary loss of ¥146 million, interim net income of ¥1,124 million, and interim net income per share of ¥35.94. |
| Reason for the revision | Operating profit, ordinary profit and interim net income exceeded plan, primarily because unit prices remained firm, although sales volume in the core domestic mushroom business was slightly below plan. |
| Consolidated / non-consolidated | Consolidated and non-consolidated |
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The main reason was that unit prices remained firm, although sales volume in the core domestic mushroom business was slightly below plan.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.